New - European Medical Journal

Continue

News

EMJ
Neurology
1 Sep 2015

PTSD in Vietnam War Veterans Reveals Lifelong Impact of Combat Service

AMERICAN veterans of the Vietnam War continue to experience post-traumatic stress disorder (PTSD) and other mental health illnesses despite…
EMJ
Neurology
28 Aug 2015

Schizophrenia: Identification of ‘Rosetta Stone’ Gene

DISCOVERY of a key role for the protein ‘disrupted in schizophrenia 1’ (DISC1) during a critical period of neural development shortly after birth may…
EMJ
General Healthcare
27 Aug 2015

Janssen Submits European Extension Marketing Authorisation Application for Paliperidone Palmitate Once-Every-Three-Months Formulation

BEERSE, Belgium, 21st August 2015 – Janssen-Cilag International NV (Janssen) today announced the submission of an Extension Marketing Authorisation…
EMJ
Urology
24 Aug 2015

New Surgical Method Preserves Kidney Function After Tumour Removal

SURGICAL technique that preserves long-term renal function by treating complex renal tumours has been performed successfully for the first time…
EMJ
Urology
24 Aug 2015

Long-Term Survival Rates Sufficient for Bladder Cancer Patients Treated With Robotic Surgery

PATIENTS diagnosed with bladder cancer (BLC) and treated with robot-assisted surgery experience similar results to those who undergo a traditional open…
EMJ
General Healthcare
21 Aug 2015

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Foster City, CA, August 20, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the company’s Marketing Authorization Application (MAA)…
EMJ
Oncology
17 Aug 2015

More Reliable Prostate Cancer Diagnoses Provided by Sensor Chip

PROSTATE cancer (PrC) diagnosis may become more efficient and reliable thanks to a new sensor chip, according to recent study data.
EMJ
Oncology
17 Aug 2015

Disabling Ability of Lymphoma to Escape Immune Response May Trigger New Treatments

RESTORING the power of natural killer (NK) cells in the vicinity of lymphoma tumours may catalyse the development of new therapies, according to…